Investigation of SLC2A1 26177A/G gene polymorphism via high resolution melting curve analysis in Malaysian patients with diabetic retinopathy

J Diabetes Complications. 2012 Sep-Oct;26(5):388-92. doi: 10.1016/j.jdiacomp.2012.05.014. Epub 2012 Jul 12.

Abstract

Purpose: In this study, we aimed to investigate the possible association between SLC2A1 26177A/G polymorphism and diabetic retinopathy (DR) in Malaysian patients with type 2 diabetes.

Methods: Genomic DNA was extracted from 211 Malaysian type 2 diabetic patients (100 without retinopathy [DNR], 111 with retinopathy) and 165 healthy controls. A high resolution melting assay developed in this study was used to detect SLC2A1 26177A/G polymorphism followed by statistical analysis.

Results: A statistically significant difference in 26177G minor allele frequency between healthy controls (19.7 %) and total patient group (26.1 %) (p<0.05, Odd ratio = 1.437, 95% Confidence interval = 1.015-2.035) as well as between healthy controls (19.7 %) and DNR patients (27.5%) (p<0.05, Odd ratio = 1.546, 95% Confidence interval = 1.024-2.336) was shown in this study. However, when compared between DR and DNR patients, there was no significant difference (p>0.05).

Conclusions: This is the first study which shows that SLC2A1 26177G allele is associated with type 2 diabetes in Malaysian population but not with DR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alleles
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / genetics*
  • Diabetes Mellitus, Type 2 / metabolism
  • Diabetic Retinopathy / genetics*
  • Diabetic Retinopathy / metabolism
  • Female
  • Gene Frequency
  • Genetic Association Studies
  • Genotyping Techniques
  • Glucose Transporter Type 1 / genetics*
  • Glucose Transporter Type 1 / metabolism
  • Heterozygote
  • Homozygote
  • Humans
  • Malaysia
  • Male
  • Middle Aged
  • Nucleic Acid Denaturation
  • Polymorphism, Single Nucleotide*
  • Real-Time Polymerase Chain Reaction

Substances

  • Glucose Transporter Type 1
  • SLC2A1 protein, human